趋化因子配体2(CXCL2)多克隆抗体(生物素标记)
Biotin-Linked Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 2 (CXCL2)
GROb; SCYB2; MIP2; GRO2; MIP2a; MGSAb; CINC2a; HSF; Macrophage inflammatory protein 2-alpha; Hematopoietic synergistic factor; Growth Regulated Oncogene Beta
- 编号LAB603Hu71
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源抗体标记
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物生物素
- 原抗体 -
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 659 ¥ 1537 ¥ 2196 ¥ 5490 ¥ 21960
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对CXCL2的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别CXCL2。
用法
免疫印迹:0.2-2µg/mL;1:250-2500
免疫组织化学:5-20µg/mL;1:25-100
免疫细胞化学:5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APB603Hu01 | 趋化因子配体2(CXCL2)活性蛋白 | Cell culture; Activity Assays. |
RPB603Hu01 | 趋化因子配体2(CXCL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB603Hu02 | 趋化因子配体2(CXCL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB603Hu03 | 趋化因子配体2(CXCL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB603Hu01 | 趋化因子配体2(CXCL2)多克隆抗体 | WB; IHC; ICC; IP. |
PAB603Hu02 | 趋化因子配体2(CXCL2)多克隆抗体 | WB,IHC |
PAB603Hu03 | 趋化因子配体2(CXCL2)多克隆抗体 | WB; IHC; ICC; IP. |
LAB603Hu71 | 趋化因子配体2(CXCL2)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAB603Hu22 | 趋化因子配体2(CXCL2)单克隆抗体 | WB; IHC; ICC; IP. |
SEB603Hu | 趋化因子配体2(CXCL2)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB603Hu | 趋化因子配体2(CXCL2)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMB603Hu | 趋化因子配体2(CXCL2)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
FEBS Journal | Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa B [PubMed: 19120450] |
PLoS One. | HIF-1α Is Essential for Effective PMN Bacterial Killing, Antimicrobial Peptide Production and Apoptosis in Pseudomonas aeruginosa Keratitis [Plos: Source] |
Physiol Genomics. | Identification of human exercise-induced myokines using secretome analysis [Pubmed:24520153] |
Diabetes | Protein Inhibitor of Activated STAT 1 (PIAS1) Protects Against Obesity-Induced Insulin Resistance by Inhibiting Inflammation Cascade in Adipose Tissue [PubMed: 26324179] |
Respiration | Bubble CPAP support after discontinuation of mechanical ventilation protects rat lungs with ventilator-induced lung injury [Pubmed:26800273] |
Scientific Reports | The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264. 7) Resistance to Mycobacterium tuberculosis H37Ra [Pubmed:26912204] |
Cellular Physiology and Biochemistry | Dexmedetomidine Alleviates HyperoxiaInduced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation [pubmed:28873369] |
Medicine (Baltimore) | Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity [Pubmed:29953010] |
Hepatology | Integrated Omics Reveals Tollip as an Aggravator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice [Pubmed: 31077413] |
Molecular Medicine Reports | IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer [Pubmed: 31173199] |
Anticancer Research | The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer [Pubmed: 31810929] |
Lab Invest | Extracellular cold-inducible RNA-binding protein regulates neutrophil extracellular trap formation and tissue damage in acute pancreatitis [Pubmed: 32709888] |
SCIENCE OF THE TOTAL ENVIRONMENT | Assessment of acute toxicological effects of molybdenum (IV) disulfide nano-and microparticles after single intratracheal administration in rats [Pubmed: 32629262] |
Autophagy | Vitamin D3 and carbamazepine protect against Clostridioides difficile infection in mice by restoring macrophage lysosome acidification [Pubmed:34989311] |
留言咨询